Rationale of ferroportin inhibition for beta-thalassemia management
-
Published:2022
Issue:2
Volume:47
Page:123
-
ISSN:0377-8282
-
Container-title:Drugs of the Future
-
language:en
-
Short-container-title:Drugs Fut
Author:
Asadov C.,Aliyeva G.,Shirinova A.,Alimirzoyeva Z.
Subject
Pharmacology (medical),Pharmacology